4 not yet recruiting, 1 recruiting. 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow SYS6002: new trials by email Literature Review of SYS6002 trials Research Report on SYS6002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma SYS6002, Investigator's Choice of Chemotherapy - Urothelial Carcinoma | Phase 3 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 406 | 2026-06-20 | 2026-04-13 |
| SYS6002 vs PADCEV in Patients With Advanced Urothelial Carcinoma SYS6002, enfortumab vedotin - Advanced Urothelial Carcinoma | Phase 2 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 100 | 2026-06-20 | 2026-01-29 |
| SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer SYS6002, Investigator's Choice of Chemotherapy - Cervical Cancer | Phase 3 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 412 | 2025-11-20 | 2025-11-17 |
| A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors sirolimus (albumin-bound), DP303c, SYS6043 - Advanced Solid Tumors | Phase 1 / Phase 2 | Recruiting | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 444 | 2025-11-13 | 2025-11-28 |
| SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC JMT101, SYS6002, SG001 - Head and Neck Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 430 | 2025-08-30 | 2025-08-27 |
Carcinoma, Transitional Cell (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Neoplasms (1)
CSPC Megalith Biopharmaceutical Co.,Ltd. (4) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)
China (1)